Search
LivaNova PLC
LIVNAdd to Watchlist
80.140USD
-0.910-1.12%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.40BMarket Cap
40.53P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of LivaNova PLC is 8.18, ranking 60 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 67.50, with a high of 86.00 and a low of 53.32.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
84.933
Target Price
+4.30%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
LivaNova PLC
LIVN
10
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Medtronic PLC
MDT
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is LivaNova PLC's expected revenue for the next quarter?
LivaNova PLC's expected revenue is 380.76M.
What is LivaNova PLC's price target?
Analysts forecast that LivaNova PLC's price target is USD 67.50, with the highest forecast at USD 86.00 and the lowest forecast at USD 53.32.
How have LivaNova PLCLIVN's recent earnings per share performed?
The market expectation was USD 0.41, while LivaNova PLCLIVN's earnings per share (EPS) for the previous quarter was USD 0.57. EPS for the next quarter is expected at USD 1.10.
What is the analyst rating for LivaNova PLC?
Based on the ratings of LivaNova PLC's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.